The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank
- PMID: 20566735
- DOI: 10.1093/rheumatology/keq155
The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank
Abstract
The National Data Bank (NDB) for rheumatic diseases is a patient-based multi-disease, multi-purpose rheumatic disease registry that has been used primarily to study patients with RA, SLE, FM and OA. It enrols patients from the community, follows up with questionnaires and validates key patient data using medical records. Rheumatologist-written programs make NDB data immediately available to analysts. The NDB has been used to develop and validate diagnostic criteria, develop new questionnaires, describe illness and comorbid disease, assesses disease outcomes and the effect of therapeutic interventions, and measure costs and cost-effectiveness.
Similar articles
-
A brief introduction to the National Data Bank for Rheumatic Diseases.Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S168-71. Clin Exp Rheumatol. 2005. PMID: 16273802
-
The National Data Bank for Rheumatic Diseases (NDB).Clin Exp Rheumatol. 2016 Sep-Oct;34(5 Suppl 101):S100-S101. Epub 2016 Oct 19. Clin Exp Rheumatol. 2016. PMID: 27762196 Review.
-
GISEA: an Italian biological agents registry in rheumatology.Reumatismo. 2011 Nov 9;63(3):155-64. doi: 10.4081/reumatismo.2011.155. Reumatismo. 2011. PMID: 22257916
-
Some principles of the development of a clinical database/national register of selected inflammatory rheumatic diseases in the Czech Republic.Int J Med Inform. 2006 Mar-Apr;75(3-4):216-23. doi: 10.1016/j.ijmedinf.2005.07.043. Epub 2005 Sep 19. Int J Med Inform. 2006. PMID: 16169767
-
The Corrona US registry of rheumatic and autoimmune diseases.Clin Exp Rheumatol. 2016 Sep-Oct;34(5 Suppl 101):S96-S99. Epub 2016 Oct 19. Clin Exp Rheumatol. 2016. PMID: 27762197 Review.
Cited by
-
Changes in Disease-Modifying Antirheumatic Drug Treatment for Patients With Rheumatoid Arthritis in the US During the COVID-19 Pandemic: A Three-Month Observational Study.Arthritis Care Res (Hoboken). 2021 Sep;73(9):1322-1331. doi: 10.1002/acr.24611. Epub 2021 Aug 6. Arthritis Care Res (Hoboken). 2021. PMID: 33787086 Free PMC article.
-
Estimates of Responsiveness, Minimally Important Differences, and Patient Acceptable Symptom State in Five Patient-Reported Outcomes Measurement Information System Short Forms in Systemic Lupus Erythematosus.ACR Open Rheumatol. 2020 Jan;2(1):53-60. doi: 10.1002/acr2.11100. Epub 2019 Dec 4. ACR Open Rheumatol. 2020. PMID: 31943975 Free PMC article.
-
Development and Implementation of a Registry of Patients Attending Multidisciplinary Pain Treatment Clinics: The Quebec Pain Registry.Pain Res Manag. 2017;2017:8123812. doi: 10.1155/2017/8123812. Epub 2017 Feb 9. Pain Res Manag. 2017. PMID: 28280406 Free PMC article.
-
Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?RMD Open. 2015 Nov 18;1(1):e000155. doi: 10.1136/rmdopen-2015-000155. eCollection 2015. RMD Open. 2015. PMID: 26629366 Free PMC article.
-
Treatment Adherence and Adherence Patterns of Tofacitinib and Self-Injectable TNFi Use in People with Rheumatoid Arthritis.ACR Open Rheumatol. 2024 Feb;6(2):72-80. doi: 10.1002/acr2.11622. Epub 2023 Dec 1. ACR Open Rheumatol. 2024. PMID: 38041515 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources